V. Leonardi

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 86 citations · Full text

Endocrine Oncology, Breast Oncology, Medicine +7

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer

Alessandra Fabi, Daniele Alesini, Enrichetta Valle et al. · The Breast · 2018 · 55 citations

Neuro-oncology, Breast Oncology, Brain Metastases +8

Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

Marina Elena Cazzaniga, G. Pinotti, Emilia Montagna et al. · The Breast · 2019 · 52 citations

Victor-6 Study, Breast Oncology, Oncology +9

Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience

Vittorio Gebbia, Salvatore Del Prete, Nicolò Borsellino et al. · Clinical Colorectal Cancer · 2006 · 43 citations

Gastrointestinal Oncology, Medicine, Colorectal Cancer +6

Gemcitabine and vinorelbine in pretreated advanced breast cancer: A pilot study

Roberto Valenza, V. Leonardi, Vittorio Gebbia et al. · Annals of Oncology · 2000 · 38 citations

Breast Oncology, Oncology, Medicine +6